Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
21.59
-0.21 (-0.96%)
At close: Nov 7, 2025, 4:00 PM EST
21.40
-0.19 (-0.88%)
After-hours: Nov 7, 2025, 7:17 PM EST
Pharvaris Market Cap
Pharvaris has a market cap or net worth of $1.56 billion as of November 7, 2025. Its market cap has increased by 30.14% in one year.
Market Cap
1.56B
Enterprise Value
1.33B
1-Year Change
30.14%
Ranking
Category
Stock Price
$21.59
Market Cap Chart
Since the IPO on February 5, 2021, Pharvaris's market cap has increased from $636.80M to $1.56B, an increase of 145.15%. That is a compound annual growth rate of 20.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 1.56B | 50.15% |
| Dec 31, 2024 | 1.04B | -28.87% |
| Dec 29, 2023 | 1.46B | 284.53% |
| Dec 30, 2022 | 380.11M | -20.27% |
| Dec 31, 2021 | 476.72M | -25.14% |
| Feb 5, 2021 | 636.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 827.67B |
| Johnson & Johnson | 449.50B |
| AbbVie | 387.34B |
| UnitedHealth Group | 293.68B |
| AstraZeneca | 263.38B |
| Novartis AG | 243.48B |
| Abbott Laboratories | 219.72B |
| Thermo Fisher Scientific | 215.06B |